Filing Details

Accession Number:
0001593968-22-000748
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-15 14:49:18
Reporting Period:
2022-03-14
Accepted Time:
2022-03-15 14:49:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
738214 Aemetis Inc AMTX Industrial Organic Chemicals (2860) 261407544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1055711 R John Block 20400 Stevens Crek Blvd, Suite 700
Cupertino CA 95014
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-14 35,000 $12.12 54,627 No 4 S Direct
Common Stock Disposition 2022-03-14 35,000 $1.72 89,627 No 4 M Direct
Common Stock Disposition 2022-03-14 1,300 $12.12 53,327 No 4 S Direct
Common Stock Disposition 2022-03-14 18,865 $12.12 34,462 No 4 S Direct
Common Stock Acquisiton 2022-03-14 10,371 $12.12 24,091 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock And Series B Preferred Option (right to buy) Disposition 2022-03-14 35,000 $1.72 35,000 $1.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-01-20 2027-01-19 No 4 M Direct
Footnotes
  1. 35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017 and were sold on 3/14/2022 in the open market.
  2. 35,000 shares, which were acquired by exercising the NQ options granted on 1/19/2017.
  3. 1,300 shares, which were acquired from the RSA grant on 1/7/2021, were sold on 3/14/2022 in the open market.
  4. 18,865 shares, which were acquired from the RSA grant on 4/8/2021, were sold on 3/14/2022 in the open market.
  5. 10,371 shares, which were acquired from the RSA grant on 1/6/2022, were sold on 3/14/2022 in the open market.
  6. As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 24,091 shares of the Issuers common stock.